Financial Toxicity and Cancer Treatment (PDQ®)–Health Professional Version
SECTIONS
- Introduction
- Financial Toxicity Associated with Cancer Care—Background and Prevalence
- Risk Factors Associated with Financial Toxicity
- Consequences of Financial Toxicity Among Cancer Patients
- Evidence Gaps and Areas for Future Research
- Changes to This Summary (08/26/2016)
- About This PDQ Summary
- View All Sections
Introduction
A number of studies demonstrate that individuals with cancer are at higher risk of experiencing financial difficulty than are individuals without cancer.[1-5] This summary reviews the extant literature onfinancial toxicity among American cancer patients and survivors.
References
- Soni A: Trends in the Five Most Costly Conditions among the U.S. Civilian Institutionalized Population, 2002 and 2012. Statistical Brief 470. Rockville, Md: Agency for Healthcare Research and Quality, 2015. Available online. Last accessed June 9, 2016.
- Bradley CJ, Yabroff KR, Warren JL, et al.: Trends in the Treatment of Metastatic Colon and Rectal Cancer in Elderly Patients. Med Care 54 (5): 490-7, 2016. [PUBMED Abstract]
- Shih YC, Smieliauskas F, Geynisman DM, et al.: Trends in the Cost and Use of Targeted Cancer Therapies for the Privately Insured Nonelderly: 2001 to 2011. J Clin Oncol 33 (19): 2190-6, 2015. [PUBMED Abstract]
- Conti RM, Fein AJ, Bhatta SS: National trends in spending on and use of oral oncologics, first quarter 2006 through third quarter 2011. Health Aff (Millwood) 33 (10): 1721-7, 2014. [PUBMED Abstract]
- Ekwueme DU, Yabroff KR, Guy GP Jr, et al.: Medical costs and productivity losses of cancer survivors--United States, 2008-2011. MMWR Morb Mortal Wkly Rep 63 (23): 505-10, 2014. [PUBMED Abstract]
.png)
No hay comentarios:
Publicar un comentario